Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 146 Pages
Report ld: 3498783
Request Sample
Customized Report
Blood Coagulometers Market Size(US$)

CAGR 2025-2031
9.1%
Market Size,2031
USD 8,695
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Blood Coagulometers was estimated to be worth US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
A blood coagulometer is an analyzer used to test the coagulation efficiency of blood so as to diagnose and assess bleeding disorders such as hemophilia or to monitor patients who are taking anticoagulant medicines such as aspirin, heparin, or warfarin.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Rising incidences of cardiovascular diseases and blood disorders are likely to have a significant impact on the coagulation analyzers market during the forecast period 2022 to 2029. Another important factor driving the expanding usage of coagulation analyzers is growing geriatric population, rising healthcare costs, technological developments, and rising obesity rates. On the other hand, emerging markets and growing reagent rental business will provide significant opportunities for the growth of the coagulation analyzer market throughout the forecast period. Key market players have launched innovative analyzers that are small in size and easy to integrate, triggering the demand for such analyzers to be widely used in various medical facilities. Furthermore, rising awareness in healthcare systems in many parts of the world has also increased the demand for such analyzers. The rapid advancement and optimization of testing facilities is also driving the growth of the industry as a whole. The subsequent proliferation of innovative healthcare facilities, treatment centers, laboratory facilities, and academic institutions has resulted in a significant increase in the demand for such analyzers. Due to the rising number of heart disease and blood disorders, the demand for these analyzers is also increasing. Due to the ease of use and performance features of these analyzers, patients are able to use these analyzers at home to assess their coagulation status. The aforementioned factors are expected to boost the global market growth.
This report aims to provide a comprehensive presentation of the global market for Blood Coagulometers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blood Coagulometers by region & country, by Type, and by Application.
The Blood Coagulometers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Coagulometers.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Coagulometers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Blood Coagulometers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Blood Coagulometers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Blood Coagulometers Product Introduction
1.2 Global Blood Coagulometers Market Size Forecast
1.2.1 Global Blood Coagulometers Sales Value (2020-2031)
1.2.2 Global Blood Coagulometers Sales Volume (2020-2031)
1.2.3 Global Blood Coagulometers Sales Price (2020-2031)
1.3 Blood Coagulometers Market Trends & Drivers
1.3.1 Blood Coagulometers Industry Trends
1.3.2 Blood Coagulometers Market Drivers & Opportunity
1.3.3 Blood Coagulometers Market Challenges
1.3.4 Blood Coagulometers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blood Coagulometers Players Revenue Ranking (2024)
2.2 Global Blood Coagulometers Revenue by Company (2020-2025)
2.3 Global Blood Coagulometers Players Sales Volume Ranking (2024)
2.4 Global Blood Coagulometers Sales Volume by Company Players (2020-2025)
2.5 Global Blood Coagulometers Average Price by Company (2020-2025)
2.6 Key Manufacturers Blood Coagulometers Manufacturing Base and Headquarters
2.7 Key Manufacturers Blood Coagulometers Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Blood Coagulometers
2.9 Blood Coagulometers Market Competitive Analysis
2.9.1 Blood Coagulometers Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Blood Coagulometers Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Coagulometers as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Standalone Analysers
3.1.2 Table Top Analysers
3.1.3 Portable Analysers
3.2 Global Blood Coagulometers Sales Value by Type
3.2.1 Global Blood Coagulometers Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Blood Coagulometers Sales Value, by Type (2020-2031)
3.2.3 Global Blood Coagulometers Sales Value, by Type (%) (2020-2031)
3.3 Global Blood Coagulometers Sales Volume by Type
3.3.1 Global Blood Coagulometers Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Blood Coagulometers Sales Volume, by Type (2020-2031)
3.3.3 Global Blood Coagulometers Sales Volume, by Type (%) (2020-2031)
3.4 Global Blood Coagulometers Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinical Laboratories
4.1.3 Others
4.2 Global Blood Coagulometers Sales Value by Application
4.2.1 Global Blood Coagulometers Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Blood Coagulometers Sales Value, by Application (2020-2031)
4.2.3 Global Blood Coagulometers Sales Value, by Application (%) (2020-2031)
4.3 Global Blood Coagulometers Sales Volume by Application
4.3.1 Global Blood Coagulometers Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Blood Coagulometers Sales Volume, by Application (2020-2031)
4.3.3 Global Blood Coagulometers Sales Volume, by Application (%) (2020-2031)
4.4 Global Blood Coagulometers Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Blood Coagulometers Sales Value by Region
5.1.1 Global Blood Coagulometers Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Blood Coagulometers Sales Value by Region (2020-2025)
5.1.3 Global Blood Coagulometers Sales Value by Region (2026-2031)
5.1.4 Global Blood Coagulometers Sales Value by Region (%), (2020-2031)
5.2 Global Blood Coagulometers Sales Volume by Region
5.2.1 Global Blood Coagulometers Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Blood Coagulometers Sales Volume by Region (2020-2025)
5.2.3 Global Blood Coagulometers Sales Volume by Region (2026-2031)
5.2.4 Global Blood Coagulometers Sales Volume by Region (%), (2020-2031)
5.3 Global Blood Coagulometers Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Blood Coagulometers Sales Value, 2020-2031
5.4.2 North America Blood Coagulometers Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Blood Coagulometers Sales Value, 2020-2031
5.5.2 Europe Blood Coagulometers Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Blood Coagulometers Sales Value, 2020-2031
5.6.2 Asia Pacific Blood Coagulometers Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Blood Coagulometers Sales Value, 2020-2031
5.7.2 South America Blood Coagulometers Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Blood Coagulometers Sales Value, 2020-2031
5.8.2 Middle East & Africa Blood Coagulometers Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blood Coagulometers Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Blood Coagulometers Sales Value
6.2.1 Key Countries/Regions Blood Coagulometers Sales Value, 2020-2031
6.2.2 Key Countries/Regions Blood Coagulometers Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Blood Coagulometers Sales Value, 2020-2031
6.3.2 United States Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Blood Coagulometers Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Blood Coagulometers Sales Value, 2020-2031
6.4.2 Europe Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Blood Coagulometers Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Blood Coagulometers Sales Value, 2020-2031
6.5.2 China Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.5.3 China Blood Coagulometers Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Blood Coagulometers Sales Value, 2020-2031
6.6.2 Japan Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Blood Coagulometers Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Blood Coagulometers Sales Value, 2020-2031
6.7.2 South Korea Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Blood Coagulometers Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Blood Coagulometers Sales Value, 2020-2031
6.8.2 Southeast Asia Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Blood Coagulometers Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Blood Coagulometers Sales Value, 2020-2031
6.9.2 India Blood Coagulometers Sales Value by Type (%), 2024 VS 2031
6.9.3 India Blood Coagulometers Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Siemens
7.1.1 Siemens Company Information
7.1.2 Siemens Introduction and Business Overview
7.1.3 Siemens Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Siemens Blood Coagulometers Product Offerings
7.1.5 Siemens Recent Development
7.2 Instrumentation Laboratory
7.2.1 Instrumentation Laboratory Company Information
7.2.2 Instrumentation Laboratory Introduction and Business Overview
7.2.3 Instrumentation Laboratory Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Instrumentation Laboratory Blood Coagulometers Product Offerings
7.2.5 Instrumentation Laboratory Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Introduction and Business Overview
7.3.3 Roche Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Roche Blood Coagulometers Product Offerings
7.3.5 Roche Recent Development
7.4 Mindray
7.4.1 Mindray Company Information
7.4.2 Mindray Introduction and Business Overview
7.4.3 Mindray Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Mindray Blood Coagulometers Product Offerings
7.4.5 Mindray Recent Development
7.5 MRC
7.5.1 MRC Company Information
7.5.2 MRC Introduction and Business Overview
7.5.3 MRC Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 MRC Blood Coagulometers Product Offerings
7.5.5 MRC Recent Development
7.6 Helena Laboratories
7.6.1 Helena Laboratories Company Information
7.6.2 Helena Laboratories Introduction and Business Overview
7.6.3 Helena Laboratories Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Helena Laboratories Blood Coagulometers Product Offerings
7.6.5 Helena Laboratories Recent Development
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Information
7.7.2 Thermo Fisher Scientific Introduction and Business Overview
7.7.3 Thermo Fisher Scientific Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Thermo Fisher Scientific Blood Coagulometers Product Offerings
7.7.5 Thermo Fisher Scientific Recent Development
7.8 ERBA Diagnostics Mannheim
7.8.1 ERBA Diagnostics Mannheim Company Information
7.8.2 ERBA Diagnostics Mannheim Introduction and Business Overview
7.8.3 ERBA Diagnostics Mannheim Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 ERBA Diagnostics Mannheim Blood Coagulometers Product Offerings
7.8.5 ERBA Diagnostics Mannheim Recent Development
7.9 Rayto Life and Analytical Sciences
7.9.1 Rayto Life and Analytical Sciences Company Information
7.9.2 Rayto Life and Analytical Sciences Introduction and Business Overview
7.9.3 Rayto Life and Analytical Sciences Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Rayto Life and Analytical Sciences Blood Coagulometers Product Offerings
7.9.5 Rayto Life and Analytical Sciences Recent Development
7.10 Nihon Kohden Corporation
7.10.1 Nihon Kohden Corporation Company Information
7.10.2 Nihon Kohden Corporation Introduction and Business Overview
7.10.3 Nihon Kohden Corporation Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Nihon Kohden Corporation Blood Coagulometers Product Offerings
7.10.5 Nihon Kohden Corporation Recent Development
7.11 Beckman Coulter Inc. (Danaher Corporation)
7.11.1 Beckman Coulter Inc. (Danaher Corporation) Company Information
7.11.2 Beckman Coulter Inc. (Danaher Corporation) Introduction and Business Overview
7.11.3 Beckman Coulter Inc. (Danaher Corporation) Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Beckman Coulter Inc. (Danaher Corporation) Blood Coagulometers Product Offerings
7.11.5 Beckman Coulter Inc. (Danaher Corporation) Recent Development
7.12 Sysmex Corporation
7.12.1 Sysmex Corporation Company Information
7.12.2 Sysmex Corporation Introduction and Business Overview
7.12.3 Sysmex Corporation Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Sysmex Corporation Blood Coagulometers Product Offerings
7.12.5 Sysmex Corporation Recent Development
7.13 Abbott Laboratories
7.13.1 Abbott Laboratories Company Information
7.13.2 Abbott Laboratories Introduction and Business Overview
7.13.3 Abbott Laboratories Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Abbott Laboratories Blood Coagulometers Product Offerings
7.13.5 Abbott Laboratories Recent Development
7.14 HORIBA Medical
7.14.1 HORIBA Medical Company Information
7.14.2 HORIBA Medical Introduction and Business Overview
7.14.3 HORIBA Medical Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 HORIBA Medical Blood Coagulometers Product Offerings
7.14.5 HORIBA Medical Recent Development
7.15 DIRUI Industrial
7.15.1 DIRUI Industrial Company Information
7.15.2 DIRUI Industrial Introduction and Business Overview
7.15.3 DIRUI Industrial Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 DIRUI Industrial Blood Coagulometers Product Offerings
7.15.5 DIRUI Industrial Recent Development
7.16 Seleo
7.16.1 Seleo Company Information
7.16.2 Seleo Introduction and Business Overview
7.16.3 Seleo Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Seleo Blood Coagulometers Product Offerings
7.16.5 Seleo Recent Development
7.17 Zircon Biotech
7.17.1 Zircon Biotech Company Information
7.17.2 Zircon Biotech Introduction and Business Overview
7.17.3 Zircon Biotech Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Zircon Biotech Blood Coagulometers Product Offerings
7.17.5 Zircon Biotech Recent Development
7.18 Beijing Succeeder Technology
7.18.1 Beijing Succeeder Technology Company Information
7.18.2 Beijing Succeeder Technology Introduction and Business Overview
7.18.3 Beijing Succeeder Technology Blood Coagulometers Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Beijing Succeeder Technology Blood Coagulometers Product Offerings
7.18.5 Beijing Succeeder Technology Recent Development
8 Industry Chain Analysis
8.1 Blood Coagulometers Industrial Chain
8.2 Blood Coagulometers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blood Coagulometers Sales Model
8.5.2 Sales Channel
8.5.3 Blood Coagulometers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Blood Coagulometers was estimated to be worth US$ 5156 million in 2025 and is projected to reach US$ 9407 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 147
USD 3950.00
(Single User License)
The global Blood Coagulometers market was valued at US$ 5156 million in 2025 and is anticipated to reach US$ 9407 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 135
USD 2900.00
(Single User License)
The global Blood Coagulometers market size was US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 109
USD 4250.00
(Single User License)
The global Blood Coagulometers market is projected to grow from US$ 4766 million in 2024 to US$ 8695 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 173
USD 4900.00
(Single User License)
The global market for Blood Coagulometers was valued at US$ 4766 million in the year 2024 and is projected to reach a revised size of US$ 8695 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published Date: 2025-01-13
Pages: 102
USD 2900.00
(Single User License)
The global market for Blood Coagulometers was estimated to be worth US$ 5156 million in 2025 and is projected to reach US$ 9407 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 147
The global Blood Coagulometers market was valued at US$ 5156 million in 2025 and is anticipated to reach US$ 9407 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 135
The global Blood Coagulometers market size was US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 109
The global Blood Coagulometers market is projected to grow from US$ 4766 million in 2024 to US$ 8695 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 173
The global market for Blood Coagulometers was valued at US$ 4766 million in the year 2024 and is projected to reach a revised size of US$ 8695 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published: 2025-01-13
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now